FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

MEDICARE DRUG BENEFIT Previous Volume 353:2739-2741 December 29, 2005 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Interview Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

The new Medicare Part D will improve access to medications for millions of Americans. One subgroup of beneficiaries, however, may inadvertently be made worse off: the 7.2 million people enrolled in both Medicaid (because they are poor) and Medicare (because they are elderly or disabled). These beneficiaries, known as the dually eligible, already receive drug benefits through state-run Medicaid programs; but as of 2006, they will be required to enroll in Medicare Part D.

Moving the dually eligible recipients of drug benefits to new federal programs raises several concerns: these beneficiaries may have problems making the transition and negotiating the . . . [Full Text of this Article]

Source Information

Dr. Elliott is a clinical senior lecturer at the University of Manchester, Manchester, United Kingdom, and a Commonwealth Fund Harkness Fellow from 2004 to 2005; Dr. Majumdar is an associate professor of medicine at the University of Alberta, Edmonton, Alta., Canada; and Dr. Gillick is an associate professor, and Dr. Soumerai a professor, of ambulatory care and prevention at Harvard Medical School and Harvard Pilgrim Health Care, Boston.

This article has been cited by other articles:

• Adams, A. S., Zhang, F., LeCates, R. F., Graves, A. J., Ross-Degnan, D., Gilden, D., McLaughlin, T. J., Lu, C., Trinacty, C. M., Soumerai, S. B. (2009). Prior Authorization for Antidepressants in Medicaid: Effects Among Disabled Dual Enrollees. Arch Intern Med 169: 750-756 [Abstract] [Full Text]  
• Jones, K., Siegel, C., Bertollo, D. N., Samuels, J. (2009). Impact of the Medicare Modernization Act on Dually Eligible Persons With Psychiatric Diagnoses: A New York State Case Study. Psychiatr. Serv. 60: 512-519 [Abstract] [Full Text]  
• Law, M. R., Ross-Degnan, D., Soumerai, S. B. (2008). Effect of Prior Authorization of Second-Generation Antipsychotic Agents on Pharmacy Utilization and Reimbursements. Psychiatr. Serv. 59: 540-546 [Abstract] [Full Text]  
• Stubbings, J., Durley, S. F., Lin, S.-J., Kliethermes, M., Aruru, M. D., Evangelista, C., Byun, M. (2007). Implementing the Medicare drug benefit in a diverse inner-city community. Am J Health Syst Pharm 64: 193-199 [Abstract] [Full Text]  
• Robinson, J. C. (2006). The Commercial Health Insurance Industry In An Era Of Eroding Employer Coverage. Health Aff (Millwood) 25: 1475-1486 [Abstract] [Full Text]  
• Soumerai, S. B., Pierre-Jacques, M., Zhang, F., Ross-Degnan, D., Adams, A. S., Gurwitz, J., Adler, G., Safran, D. G. (2006). Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.. Arch Intern Med 166: 1829-1835 [Abstract] [Full Text]  
• Federman, A. D., Alexander, G. C., Shrank, W. H. (2006). A Practical Physicians' Guide to the Medicare Drug Benefit Plan. Mayo Clin Proc. 81: 1217-1221 [Full Text]  
• Park, J. M., Hariprasad, R., Park, L. T. (2006). Medicare Part D and Decompensation. Psychiatr. Serv. 57: 722-723 [Full Text]